Evidence map›Paper›PMID 33968076›Full record

ArticleFrontiers in immunology2021

Case Report:

Arthur Dujardin, Arnaud de La Blanchardière, Julia Dina, Karl Stefic, Christophe Ravel, Julie Bonhomme, Renaud Verdon, Anna Lucie Fournier

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Arthur DujardinInfectious Diseases Department, Caen University Hospital, Caen, France.
Arnaud de La BlanchardièreInfectious Diseases Department, Caen University Hospital, Caen, France.
Julia DinaVirology Department, Normandie Univ, UNICAEN, Normandie University Hospital, Caen, France.
Karl SteficVirology Laboratory, Tours Hospital, Tours, France.
Christophe RavelNational Reference Centre for Leishmaniasis, University Hospital Centre of Montpellier, MiVEGEC, University of Montpellier, Montpellier, France.
Julie BonhommeNormandie University, UNICAEN, Groupe de Recherche sur l'Adaptation Microbienne (GRAM 2.0), Normandie Univ, UNICAEN, UNIROUEN, GRAM 2.0, Caen, France.
Renaud VerdonInfectious Diseases Department, Caen University Hospital, Caen, France.
Anna Lucie FournierInfectious Diseases Department, Caen University Hospital, Caen, France.
Normandie Université · FRUniversité de Caen Normandie · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of a severe visceral leishmaniasis revealing an HIV-1 infection presenting as an acute primary infection. A young French man living in Paris with history of unprotected sex with a recent male partner and recent travel in Greece was admitted in our Infectious Diseases Department, presenting with acute febrile psychotic disorder, and positive HIV-1 serology with high viral load, very low CD4

Indexed as

CoinfectionHIV TestingAdultAnti-HIV AgentsAntiprotozoal AgentsBone Marrow ExaminationCD4 Lymphocyte CountHIV-1HIV InfectionsHumansLeishmaniasis, VisceralLymphohistiocytosis, HemophagocyticMalePredictive Value of TestsSerologic TestsSeverity of Illness IndexAnti-HIV AgentsAntiprotozoal Agentsbone marrow aspiratehemophagocytic lymphohistiocytosisHIVpancytopeniavisceral leishmaniasis

Identifiers

PMID33968076
PMCPMC8097161
OpenAlexW3153912809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.